[1] 魏国强,夏涛.系统性红斑狼疮合并腹痛外科治疗2例分析[J]. 中国全科医学,2012,15(6):708-709. [2] HIRAKI L T, FELDMAN C H, LIU J, et al. Prevalence,incidence,and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US medicaid beneficiary population[J]. Arthritis Rheum, 2012, 64(8):2669-2676. [3] PEGOREIGOSA J M, COBOIBANEZ T, CALVOALEN J, et al. Efficacy and safety of nonbiologic immunosuppressants in the treatment of nonrenal systemic lupus erythematosus:A systematic review[J]. Arthritis Care Res, 2013,65(11):1775. [4] HOCHBERG M C. Updating the American College of Rheuma tology reviscd criteria for the classification of systemic lupus ery-thematosus[J]. Arthritis Rheum, 1997,40(9):175. [5] FEI Y, SHI X, GAN F, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years[J]. Clin Rheumatol,2014,33( 1) : 57. [6] 李群苑,张科.甲氨蝶呤治疗系统性红斑狼疮的临床疗效及安全性分析[J]. 吉林医学,2014,35(13):2762-2764. [7] 张羽,杨静.小剂量激素联合甲氨蝶呤、羟氯喹治疗系统性红斑狼疮的临床观察[J]. 西部医学, 2010,22(11): 2081-2082;2085. [8] 杨岫岩.系统性红斑狼疮的目标治疗[J]. 实用医院临床杂志,2011,8(2):23. [9] 邱茜,杨岫岩.经典抗风湿药甲氨蝶呤的新观念[J]. 中华内科杂志,2010,49(10):820. [10] 黄银群,林秋强,陈渍才,等.抗ds-DNA抗体、AnuA和抗rRNP抗体联合检测对系统性红斑狼疮的诊断价值[J]. 现代医院,2015,152(6):73-75. |